Does HIV cause depletion of CD4+ T cells in vivo by the induction of apoptosis?

Immunology and Cell Biology

Volumn 77, Issue 1, 1999, Pages 90-98

  Jaworowski, Anthony ^a   Crowe, Suzanne M ^a  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

Author keywords

Acquired immunodeficiency syndrome; Apoptosis; CD4+ T lymphocytes; CD95; Monocyte macrophages

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE DEPLETION; MACROPHAGE; MONOCYTE; REVIEW; VIRUS PATHOGENESIS;

ANTIGENS, CD95; APOPTOSIS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FAS LIGAND PROTEIN; HIV; HIV INFECTIONS; HUMANS; LYMPHOPENIA; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MONOCYTES;

EID: 0032991199     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1999.00798.x     Document Type: Review

References (107)

1. 1 World Health Organization. WHO Report on the global HIV/AIDS epidemic, June 1998. www.who.int/emc-hiv/ global_report/index.html
2. 2 Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J. Acquir. Immune Defic. Syndr. 1991; 4: 770-6.
3. 3 Ameisen JC, Capron A. Cell dysfunction and depletion in AIDS: The programmed cell death hypothesis. Immunol. Today 1991; 12: 102-5.
4. 4 Harper ME, Marselle LM, Gallo RC, Wong-Staal F. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc. Natl Acad. Sci. USA 1986; 83: 772-6.
5. 5 Muro-Cacho CA, Pantaleo G, Fauci AS. Analysis of apoptosis in lymph nodes of HIV-infected persons. J. Immunol. 1995; 154: 5555-66.
6. 6 Finkel TH, Tudor-Williams G, Banda NK et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nature Med. 1995; 1: 129-34.
7. 7 Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373: 123-6.
8. 8 Wei X, Ghosh SK, Taylor ME et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373: 117-22.
9. 9 Gandhi RT, Chen BK, Straus SE, Dale JK, Lenardo MJ, Baltimore D. HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism. J. Exp. Med. 1998; 187: 1113-22.
10. 10 Noraz N, Gozlan J, Corbeil J, Brunner T, Spector SA. HIV-induced apoptosis of activated primary CD4+ T lymphocytes is not mediated by Fas-Fas ligand. AIDS 1997; 11: 1671-80.
11. 11 Yagi T, Sugimoto A, Tanaka M et al. Fas/FasL interaction is not involved in apoptosis of activated CD4+ T cells upon HIV-1 infection in vitro. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1998; 18: 307-15.
12. 12 Herbein G, Van Lint C, Lovett JL, Verdin E. Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes. J. Virol. 1998; 72: 660-70.
13. 13 Lifson JD, Reyes GR, McGrath MS, Stein BS, Engleman EG. AIDS retrovirus induced cytopathology: Giant cell formation and involvement of CD4 antigen. Science 1986; 232: 1123-7.
14. 14 Lifson JD, Feinberg MB, Reyes GR et al. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature 1986; 323: 725-8.
15. 15 Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 1986; 322: 470-4.
16. 16 Yoffe B, Lewis DE, Petrie BL, Noonan CA, Melnick JL, Hollinger FB. Fusion as a mediator of cytolysis in mixtures of uninfected CD4+ lymphocytes and cells infected by human immunodeficiency virus. Proc. Natl Acad. Sci. USA 1987; 84: 1429-33.
17. 17 Somasundaran M, Robinson HL. A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion. J. Virol. 1987; 61: 3114-19.
18. 18 Stevenson M, Meier C, Mann AM, Chapman N, Wasiak A. Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: Mechanism for persistence in AIDS. Cell 1988; 53: 483-96.
19. 19 Janeway C. Immune recognition. Mls: makes a little sense. Nature 1991; 349: 459-61.
20. 20 Imberti L, Sottini A, Bettinardi A, Puoti M, Primi D. Selective depletion in HIV infection of T cells that bear specific T cell receptor V β sequences. Science 1991; 254: 860-2.
21. 21 Zinkernagel RM, Hengartner H. T cell-mediated immunopathology versus direct cytolysis by virus: Implications for HIV and AIDS. Immunol. Today 1994; 15: 262-8.
22. 22 Fauci AS, Schnittman SM, Poli G, Koenig S, Pantaleo G. NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 1991; 114: 678-93.
23. 23 Golding H, Robey FA, Gates III FT et al. Identification of homologous regions in human immunodeficiency virus 1 gp41 and human MHC class II β 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J. Exp. Med. 1988; 167: 914-23.
24. 24 Habeshaw JA, Dalgleish AG, Bountiff L et al. AIDS pathogenesis: HIV envelope and its interaction with cell proteins. Immunol. Today 1990; 11: 418-25.
25. 25 Mittler RS, Hoffmann MK. Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. Science 1989; 245: 1380-2.
26. 26 Zagury D, Bernard J, Leonard R et al. Long-term cultures of HTLV-III-infected T cells: A model of cytopathology of T-cell depletion in AIDS. Science 1986; 231: 850-3.
27. 27 Gougeon ML, Olivier R, Garcia S et al. Demonstration of an engagement process towards cell death by apoptosis in lymphocytes of HIV infected patients. C. R. Acad. Sci. III 1991; 312: 529-37 (in French).
28. 28 Groux H, Monte D, Bourrez JM, Capron A, Ameisen JC. Activation of CD4+ T-lymphocytes in asymptomatic HIV infected patients induce the program action of lymphocyte death by apoptosis. C. R. Acad. Sci. III 1991; 312: 599-606 (in French).
29. 29 Laurent-Crawford AG, Krust B, Muller S et al. The cytopathic effect of HIV is associated with apoptosis. Virology 1991; 185: 829-39.
30. 30 Terai C, Kornbluth RS, Pauza CD, Richman DD, Carson DA. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J. Clin. Invest. 1991; 87: 1710-15.
31. 31 Jaleco AC, Covas MJ, Victorino RM. Analysis of lymphocyte cell death and apoptosis in HIV-2-infected patients. Clin. Exp. Immunol. 1994; 98: 185-9.
32. 32 Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer 1972; 26: 239-57.
33. 33 Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 1992; 148: 2207-16.
34. 34 Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 1993; 14: 131-6.
35. 35 Bonyhadi ML, Rabin L, Salimi S et al. HIV induces thymus depletion in vivo. Nature 1993; 363: 728-32.
36. 36 Stanley SK, McCune JM, Kaneshima H et al. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J. Exp. Med. 1993; 178: 1151-63.
37. 37 Su L, Kaneshima H, Bonyhadi M et al. HIV-1-induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo. Immunity 1995; 2: 25-36.
38. 38 Jamieson BD, Uittenbogaart CH, Schmid I, Zack JA. High viral burden and rapid CD4+ cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo. J. Virol. 1997; 71: 8245-53.
39. 39 Cotton MF, Cassella C, Rapaport EL, Tseng PO, Marschner S, Finkel TH. Apoptosis in HIV-1 infection. Behring Inst. Mitt. 1996; 97: 220-31.
40. 40 Groux H, Torpier G, Monte D, Mouton Y, Capron A, Ameisen JC. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 1992; 175: 331-40.
41. 41 Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F. Programmed death of T cells in HIV-1 infection. Science 1992; 257: 217-19.
42. 42 Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Kalyanaraman VS, Pahwa S. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 1993; 82: 3392-400.
43. 43 Sarin A, Clerici M, Blatt SP, Hendrix CW, Shearer GM, Henkart PA. Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors. J. Immunol. 1994; 153: 862-72.
44. 44 Lewis DE, Ng-Tang DS, Adu-Oppong A, Schober W, Rodgers JR. Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J. Immunol. 1994; 153: 412-20.
45. 45 Banda NK, Bernier J, Kurahara DK et al. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 1992; 176: 1099-106.
46. 46 Martin SJ, Matear PM, Vyakarnam A. HIV-1 infection of human CD4+ T cells in vitro. Differential induction of apoptosis in these cells. J. Immunol. 1994; 152: 330-42.
47. 47 Meyaard L, Otto SA, Keet IPM, Roos MTL, Miedema F. Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease. J Clin. Invest. 1994; 93: 982-8.
48. 48 Rothen M, Gratzl S, Hirsch HH, Moroni C. Apoptosis in HIV-infected individuals is an early marker occurring independently of high viremia. AIDS Res. Hum. Retroviruses 1997; 13: 771-9.
49. 49 Gougeon ML, Lecoeur H, Dulioust A et al. Programmed cell death in peripheral lymphocytes from HIV-infected persons: Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J. Immunol. 1996; 156: 3509-20.
50. 50 Karmochkine M, Parizot C, Calvez V et al. Susceptibility of peripheral blood mononuclear cells to apoptosis is correlated to plasma HIV load. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1998; 17: 419-23.
51. 51 Alderson MR, Tough TW, Davis-Smith T et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 1995; 181: 71-7.
52. 52 Ju ST, Panka DJ, Cui H et al. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373: 444-8.
53. 53 Brunner T, Mogil RJ, LaFace D et al. Cell-autonomous Fas (CD95) /Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995; 373: 441-4.
54. 54 Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-1/ (Fas/CD95). Nature 1995; 373: 438-41.
55. 55 Kaplan D, Sieg S. Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease. J. Virol. 1998; 72: 6279-82.
56. 56 Debatin KM, Fahrig-Faissner A, Enenkel-Stoodt S, Kreuz W, Benner A, Krammer PH. High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood 1994; 83: 3101-3.
57. 57 Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA, Herzenberg LA. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 1995; 181: 2029-36.
58. 58 Aries SP, Schaaf B, Muller C, Dennin RH, Dalhoff K. Fas (CD95) expression on CD4+ T cells from HIV-infected patients increases with disease progression. J. Mol. Med. 1995; 73: 591-3.
59. 59 McCloskey TW, Oyaizu N, Kaplan M, Pahwa S. Expression of the Fas antigen in patients infected with human immunodeficiency virus. Cytometry 1995; 22: 111-14.
60. 60 Gehri R, Hahn S, Rothen M, Steuerwald M, Nuesch R, Erb P. The Fas receptor in HIV infection: Expression on peripheral blood lymphocytes and role in the depletion of T cells. Aids 1996; 10: 9-16.
61. 61 Silvestris F, Cafforio P, Frassanito MA et al. Overexpression of Fas antigen on T cells in advanced HIV-1 infection: Differential ligation constantly induces apoptosis. Aids 1996; 10: 131-41.
62. 62 Bohler T, Baumler C, Herr I, Groll A, Kurz M, Debatin KM. Activation of the CD95 system increases with disease progression in human immunodeficiency virus type 1-infected children and adolescents. Pediatr. Infect. Dis. J. 1997; 16: 754-9.
63. 63 Sloand EM, Young NS, Kumar P, Weichold FF, Sato T, Maciejewski JP. Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: Effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication. Blood 1997; 89: 1357-63.
64. 64 Estaquier J, Tanaka M, Suda T, Nagata S, Golstein P, Ameisen JC. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: Differential in vitro preventive effect of cytokincs and protease antagonists. Blood 1996; 87: 4959-66.
65. 65 McCloskey TW, Oyaizu N, Bakshi S, Kowalski R, Kohn N, Pahwa S. CD95 expression and apoptosis during pediatric HIV infection: Early upregulation of CD95 expression. Clin. Immunol. Immunopathol. 1998; 87: 33-41.
66. 66 Baumler CB, Bohler T, Herr I, Benner A, Krammer PH, Debatin KM. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood 1996; 88: 1741-6.
67. 67 Mitra D, Steiner M, Lynch DH, Staiano-Coico L, Laurence J. HIV-1 upregulates Fas ligand expression in CD4+ T cells in vitro and in vivo: Association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid. Immunology 1996; 87: 581-5.
68. 68 Westendorp MO, Frank R, Ochsenbauer C et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995; 375: 497-500.
69. 69 Katsikis PD, Garcia-Ojeda ME, Torres-Roca JF et al. Interleukin-1 b converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection. J. Exp. Med. 1997; 186: 1365-72.
70. 70 Katsikis PD, Garcia-Ojeda ME, Wunderlich ES et al. Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals. Int. Immunol. 1996; 8: 1311-17.
71. 71 Oberg HH, Sanzenbacher R, Lengl-Janssen B et al. Ligation of cell surface CD4 inhibits activation-induced death of human T lymphocytes at the level of Fas ligand expression. J. Immunol. 1997; 159: 5742-9.
72. 72 Bergamini A, Capozzi M, Piacentini M. Macrophage-colony stimulating factor (M-CSF) stimulation induces cell death in HIV-infected human monocytes. Immunol. Lett. 1994; 42: 35-40.
73. 73 Bergamini A, Dini L, Capozzi M et al. Human immunodeficiency virus-induced cell death in cytokine-treated macrophages can be prevented by compounds that inhibit late stages of viral replication. J. Infect. Dis. 1996; 173: 1367-78.
74. 74 DeLuca C, Kwon H, Pelletier N, Wainberg MA, Hiscott J. NF-kβ protects HIV-1-infected myeloid cells from apoptosis. Virology 1998; 244: 27-38.
75. 75 Badley AD, McElhinny JA, Leibson PJ, Lynch DH, Alderson MR, Paya CV. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 1996; 70: 199-206.
76. 76 Sieg S, Smith D, Yildirim Z, Kaplan D. Fas ligand deficiency in HIV disease. Proc. Natl Acad. Sci. USA 1997; 94: 5860-5.
77. 77 Badley AD, Dockrell D, Simpson M et al. Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J. Exp. Med. 1997; 185: 55-64.
78. 78 Dockrell DH, Badley AD, Villacian JS et al. The expression of Fas ligand by macrophages and its upregulation by human immunodeficiency virus infection. J. Clin. Invest. 1998; 101: 2394-405.
79. 79 Cottrez F, Manca F, Dalgleish AG, Arenzana-Seisdedos F, Capron A, Groux H. Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule. J. Clin. Invest. 1997; 99: 257-66.
80. 80 Kornbluth RS. Significance of T cell apoptosis for macrophages in HIV infection. J. Leukoc. Biol 1994; 56: 247-56.
81. 81 Schuitemaker H, Meyaard L, Kootstra NA et al. Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants. J. Infect. Dis. 1993; 168: 1140-7.
82. 82 Wang L, Klimpel GR, Planas JM, Li H, Cloyd MW. Apoptotic killing of CD4+ T lymphocytes in HIV-1-infected PHA-stimulated PBL cultures is mediated by CD8+ LAK cells. Virology 1998; 241: 169-80.
83. 83 Jones M, Olafson K, Del Bigio MR, Peeling J, Nath A. Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. J. Neuropathol. Exp. Neurol. 1998; 57: 563-70.
84. 84 McCloskey TW, Ott M, Tribble E et al. Dual role of HIV Tat in regulation of apoptosis in T cells. J. Immunol. 1997; 158: 1014-19.
85. 85 Purvis SF, Jacobberger JW, Sramkoski RM, Patki AH, Lederman MM. HIV type 1 Tat protein induces apoptosis and death in Jurkat cells. AIDS Res. Hum. Retroviruses 1995; 11: 443-50.
86. 86 Zauli G, Gibellini D. The human immunodeficiency virus type-1 (HIV-1) Tat protein and Bcl-2 gene expression. Leuk. Lymphoma 1996; 23: 551-60.
87. 87 Zauli G, Gibellini D, Milani D et al. Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res. 1993; 53: 4481-5.
88. 88 Korant BD, Strack P, Frey MW, Rizzo CJ. A cellular anti-apoptosis protein is cleaved by the HIV-1 protease. Adv. Exp. Med. Biol. 1998; 436: 27-9.
89. 89 Ayyavoo V, Mahboubi A, Mahalingam S et al. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor κB. Nature Med. 1997; 3: 1117-23.
90. 90 Conti L, Rainaldi G, Matarrese P et al. The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: Possible implications for the pathogenesis of AIDS. J. Exp. Med. 1998; 187: 403-13.
91. 91 Stewart SA, Poon B, Jowett JBM, Chen ISY. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 1997; 71: 5579-92.
92. 92 Strack PR, Frey MW, Rizzo CJ et al. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc. Natl Acad. Sci. USA 1996; 93: 9571-6.
93. 93 Okada H, Takei R, Tashiro M. HIV-1 Nef protein-induced apoptotic cytolysis of a broad spectrum of uninfected human blood cells independently of CD95 (Fas). FEBS Lett. 1997; 414: 603-6.
94. 94 Chen BK, Feinberg MB, Baltimore D. The κB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth. J. Virol. 1997; 71: 5495-504.
95. 95 Bachelerie F, Alcami J, Arenzana-Seisdedos F, Virelizier JL. HIV enhancer activity perpetuated by NFκβ induction on infection of monocytes. Nature 1991; 350: 709-12.
96. 96 Roulston A, D'Addario M, Boulerice F, Caplan S, Wainberg MA, Hiscott J. Induction of monocytic differentiation and NFκβ-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells. J. Exp. Med. 1992; 175: 751-63.
97. 97 Roulston A, Beauparlant P, Rice N, Hiscott J. Chronic human immunodeficiency virus type 1 infection stimulates distinct NFκβ/rel DNA binding activities in myelomonoblastic cells. J. Virol. 1993; 67: 5235-46.
98. 98 McElhinny JA, MacMorran WS, Bren GD, Ten RM, Israel A, Paya CV. Regulation of IκB alpha and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus. J Virol. 1995; 69: 1500-9.
99. 99 DeLuca C, Roulston A, Koromilas A, Wainberg MA, Hiscott J. Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NFκβ/Rel pathway via enhanced IκBalpha degradation. J. Virol. 1996; 70: 5183-93.
100. 100 Lewin SR, Lambert P, Deacon NJ, Mills J, Crowe SM. Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: A possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages. J. Virol. 1997; 71: 2114-19.
101. 101 Wang CY, Mayo MW, Baldwin Jr AS. TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NFκβ. Science 1996; 274: 784-7.
102. 102 Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NFκβ. Science 1996; 274: 787-9.
103. 103 Beg AA, Baltimore D. An essential role for NFκβ in preventing TNF-alpha-induced cell death. Science 1996; 274: 782-4.
104. 104 Mayo MW, Wang CY, Cogswell PC et al. Requirement of NF-κβ activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 1997; 278: 1812-15.
105. 105 Antoni BA, Sabbatini P, Rabson AB, White E. Inhibition of apoptosis in human immunodeficiency virus-infected cells enhances virus production and facilitates persistent infection. J. Virol. 1995; 69: 2384-92.
106. 106 Sandstrom PA, Pardi D, Goldsmith CS, Chengying D, Diamond AM, Folks TM. bcl-2 expression facilitates human immunodeficiency virus type-1 mediated cytopathic effects during acute spreading infections. J. Virol. 1996; 70: 4617-22.
107. 107 Chinnaiyan AM, Woffendin C, Dixit VM, Nabel GJ. The inhibition of pro-apoptotic ICE-like proteases enhances HIV replication. Nature Med. 1997; 3: 333-7.